Global Enteral Nutrition and Parenteral Nutrition Market Outlook, In‑Depth Analysis & Forecast to 2031

1 Study Coverage
1.1 Introduction to Enteral Nutrition and Parenteral Nutrition: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Enteral Nutrition and Parenteral Nutrition Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Oral/Tube Feeding
1.2.3 Intravenous Injection
1.3 Market Segmentation by Application
1.3.1 Global Enteral Nutrition and Parenteral Nutrition Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital Clinic
1.3.3 Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Enteral Nutrition and Parenteral Nutrition Revenue Estimates and Forecasts 2020-2031
2.2 Global Enteral Nutrition and Parenteral Nutrition Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Enteral Nutrition and Parenteral Nutrition Sales Estimates and Forecasts 2020-2031
2.4 Global Enteral Nutrition and Parenteral Nutrition Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Enteral Nutrition and Parenteral Nutrition Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Enteral Nutrition and Parenteral Nutrition Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Oral/Tube Feeding Market Size by Manufacturers
3.5.2 Intravenous Injection Market Size by Manufacturers
3.6 Global Enteral Nutrition and Parenteral Nutrition Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Enteral Nutrition and Parenteral Nutrition Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Enteral Nutrition and Parenteral Nutrition Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Enteral Nutrition and Parenteral Nutrition Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Enteral Nutrition and Parenteral Nutrition Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Enteral Nutrition and Parenteral Nutrition Sales and Revenue by Type (2020-2031)
6.4 North America Enteral Nutrition and Parenteral Nutrition Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Enteral Nutrition and Parenteral Nutrition Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Enteral Nutrition and Parenteral Nutrition Sales and Revenue by Type (2020-2031)
7.4 Europe Enteral Nutrition and Parenteral Nutrition Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Enteral Nutrition and Parenteral Nutrition Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Enteral Nutrition and Parenteral Nutrition Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Enteral Nutrition and Parenteral Nutrition Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Enteral Nutrition and Parenteral Nutrition Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Enteral Nutrition and Parenteral Nutrition Sales and Revenue by Type (2020-2031)
9.4 Central and South America Enteral Nutrition and Parenteral Nutrition Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Enteral Nutrition and Parenteral Nutrition Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Enteral Nutrition and Parenteral Nutrition Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Enteral Nutrition and Parenteral Nutrition Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Enteral Nutrition and Parenteral Nutrition Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Business Overview
11.1.3 Abbott Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.1.4 Abbott Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Abbott Enteral Nutrition and Parenteral Nutrition Sales by Product in 2024
11.1.6 Abbott Enteral Nutrition and Parenteral Nutrition Sales by Application in 2024
11.1.7 Abbott Enteral Nutrition and Parenteral Nutrition Sales by Geographic Area in 2024
11.1.8 Abbott Enteral Nutrition and Parenteral Nutrition SWOT Analysis
11.1.9 Abbott Recent Developments
11.2 B. Braun
11.2.1 B. Braun Corporation Information
11.2.2 B. Braun Business Overview
11.2.3 B. Braun Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.2.4 B. Braun Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 B. Braun Enteral Nutrition and Parenteral Nutrition Sales by Product in 2024
11.2.6 B. Braun Enteral Nutrition and Parenteral Nutrition Sales by Application in 2024
11.2.7 B. Braun Enteral Nutrition and Parenteral Nutrition Sales by Geographic Area in 2024
11.2.8 B. Braun Enteral Nutrition and Parenteral Nutrition SWOT Analysis
11.2.9 B. Braun Recent Developments
11.3 Baxter
11.3.1 Baxter Corporation Information
11.3.2 Baxter Business Overview
11.3.3 Baxter Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.3.4 Baxter Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Baxter Enteral Nutrition and Parenteral Nutrition Sales by Product in 2024
11.3.6 Baxter Enteral Nutrition and Parenteral Nutrition Sales by Application in 2024
11.3.7 Baxter Enteral Nutrition and Parenteral Nutrition Sales by Geographic Area in 2024
11.3.8 Baxter Enteral Nutrition and Parenteral Nutrition SWOT Analysis
11.3.9 Baxter Recent Developments
11.4 BBCA Pharmaceutical
11.4.1 BBCA Pharmaceutical Corporation Information
11.4.2 BBCA Pharmaceutical Business Overview
11.4.3 BBCA Pharmaceutical Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.4.4 BBCA Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 BBCA Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales by Product in 2024
11.4.6 BBCA Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales by Application in 2024
11.4.7 BBCA Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales by Geographic Area in 2024
11.4.8 BBCA Pharmaceutical Enteral Nutrition and Parenteral Nutrition SWOT Analysis
11.4.9 BBCA Pharmaceutical Recent Developments
11.5 Biokin Pharmaceutical
11.5.1 Biokin Pharmaceutical Corporation Information
11.5.2 Biokin Pharmaceutical Business Overview
11.5.3 Biokin Pharmaceutical Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.5.4 Biokin Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Biokin Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales by Product in 2024
11.5.6 Biokin Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales by Application in 2024
11.5.7 Biokin Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales by Geographic Area in 2024
11.5.8 Biokin Pharmaceutical Enteral Nutrition and Parenteral Nutrition SWOT Analysis
11.5.9 Biokin Pharmaceutical Recent Developments
11.6 China Meheco Kangli
11.6.1 China Meheco Kangli Corporation Information
11.6.2 China Meheco Kangli Business Overview
11.6.3 China Meheco Kangli Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.6.4 China Meheco Kangli Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 China Meheco Kangli Recent Developments
11.7 Cisen
11.7.1 Cisen Corporation Information
11.7.2 Cisen Business Overview
11.7.3 Cisen Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.7.4 Cisen Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Cisen Recent Developments
11.8 Danone
11.8.1 Danone Corporation Information
11.8.2 Danone Business Overview
11.8.3 Danone Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.8.4 Danone Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Danone Recent Developments
11.9 Fresenius Kabi
11.9.1 Fresenius Kabi Corporation Information
11.9.2 Fresenius Kabi Business Overview
11.9.3 Fresenius Kabi Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.9.4 Fresenius Kabi Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Fresenius Kabi Recent Developments
11.10 Grand Life Sciences
11.10.1 Grand Life Sciences Corporation Information
11.10.2 Grand Life Sciences Business Overview
11.10.3 Grand Life Sciences Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.10.4 Grand Life Sciences Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Grand Life Sciences Recent Developments
11.11 Haisco Pharmaceutical Group
11.11.1 Haisco Pharmaceutical Group Corporation Information
11.11.2 Haisco Pharmaceutical Group Business Overview
11.11.3 Haisco Pharmaceutical Group Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.11.4 Haisco Pharmaceutical Group Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Haisco Pharmaceutical Group Recent Developments
11.12 JW Pharmaceutical
11.12.1 JW Pharmaceutical Corporation Information
11.12.2 JW Pharmaceutical Business Overview
11.12.3 JW Pharmaceutical Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.12.4 JW Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 JW Pharmaceutical Recent Developments
11.13 Kelun Pharma
11.13.1 Kelun Pharma Corporation Information
11.13.2 Kelun Pharma Business Overview
11.13.3 Kelun Pharma Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.13.4 Kelun Pharma Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Kelun Pharma Recent Developments
11.14 King York
11.14.1 King York Corporation Information
11.14.2 King York Business Overview
11.14.3 King York Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.14.4 King York Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 King York Recent Developments
11.15 Lionco Pharmaceutical
11.15.1 Lionco Pharmaceutical Corporation Information
11.15.2 Lionco Pharmaceutical Business Overview
11.15.3 Lionco Pharmaceutical Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.15.4 Lionco Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Lionco Pharmaceutical Recent Developments
11.16 Lummy
11.16.1 Lummy Corporation Information
11.16.2 Lummy Business Overview
11.16.3 Lummy Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.16.4 Lummy Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Lummy Recent Developments
11.17 Medisan
11.17.1 Medisan Corporation Information
11.17.2 Medisan Business Overview
11.17.3 Medisan Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.17.4 Medisan Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Medisan Recent Developments
11.18 Medtrition
11.18.1 Medtrition Corporation Information
11.18.2 Medtrition Business Overview
11.18.3 Medtrition Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.18.4 Medtrition Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.18.5 Medtrition Recent Developments
11.19 Nestlé S.A.
11.19.1 Nestlé S.A. Corporation Information
11.19.2 Nestlé S.A. Business Overview
11.19.3 Nestlé S.A. Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.19.4 Nestlé S.A. Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.19.5 Nestlé S.A. Recent Developments
11.20 Otsuka Pharmaceutical
11.20.1 Otsuka Pharmaceutical Corporation Information
11.20.2 Otsuka Pharmaceutical Business Overview
11.20.3 Otsuka Pharmaceutical Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.20.4 Otsuka Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.20.5 Otsuka Pharmaceutical Recent Developments
11.21 Pfizer
11.21.1 Pfizer Corporation Information
11.21.2 Pfizer Business Overview
11.21.3 Pfizer Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.21.4 Pfizer Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.21.5 Pfizer Recent Developments
11.22 Teva Pharmaceutical
11.22.1 Teva Pharmaceutical Corporation Information
11.22.2 Teva Pharmaceutical Business Overview
11.22.3 Teva Pharmaceutical Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.22.4 Teva Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.22.5 Teva Pharmaceutical Recent Developments
11.23 Xi'an Libang Pharmaceutical
11.23.1 Xi'an Libang Pharmaceutical Corporation Information
11.23.2 Xi'an Libang Pharmaceutical Business Overview
11.23.3 Xi'an Libang Pharmaceutical Enteral Nutrition and Parenteral Nutrition Product Models, Descriptions and Specifications
11.23.4 Xi'an Libang Pharmaceutical Enteral Nutrition and Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2020-2025)
11.23.5 Xi'an Libang Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Enteral Nutrition and Parenteral Nutrition Industry Chain
12.2 Enteral Nutrition and Parenteral Nutrition Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Enteral Nutrition and Parenteral Nutrition Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Enteral Nutrition and Parenteral Nutrition Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Enteral Nutrition and Parenteral Nutrition Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Enteral Nutrition and Parenteral Nutrition Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

List of Tables
Table 1. Global Enteral Nutrition and Parenteral Nutrition Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Enteral Nutrition and Parenteral Nutrition Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Enteral Nutrition and Parenteral Nutrition Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Enteral Nutrition and Parenteral Nutrition Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Enteral Nutrition and Parenteral Nutrition Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Enteral Nutrition and Parenteral Nutrition Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Enteral Nutrition and Parenteral Nutrition Sales by Region (2020-2025) & (K Units)
Table 8. Global Enteral Nutrition and Parenteral Nutrition Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Enteral Nutrition and Parenteral Nutrition Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Enteral Nutrition and Parenteral Nutrition Sales Share by Manufacturers (2020-2025)
Table 12. Global Enteral Nutrition and Parenteral Nutrition Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Enteral Nutrition and Parenteral Nutrition Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Enteral Nutrition and Parenteral Nutrition by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enteral Nutrition and Parenteral Nutrition as of 2024)
Table 16. Global Enteral Nutrition and Parenteral Nutrition Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Enteral Nutrition and Parenteral Nutrition Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Enteral Nutrition and Parenteral Nutrition Manufacturing Base and Headquarters
Table 19. Global Enteral Nutrition and Parenteral Nutrition Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Enteral Nutrition and Parenteral Nutrition Sales by Type (2020-2025) & (K Units)
Table 23. Global Enteral Nutrition and Parenteral Nutrition Sales by Type (2026-2031) & (K Units)
Table 24. Global Enteral Nutrition and Parenteral Nutrition Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Enteral Nutrition and Parenteral Nutrition Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Enteral Nutrition and Parenteral Nutrition ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Enteral Nutrition and Parenteral Nutrition Sales by Application (2020-2025) & (K Units)
Table 29. Global Enteral Nutrition and Parenteral Nutrition Sales by Application (2026-2031) & (K Units)
Table 30. Enteral Nutrition and Parenteral Nutrition High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Enteral Nutrition and Parenteral Nutrition Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Enteral Nutrition and Parenteral Nutrition Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Enteral Nutrition and Parenteral Nutrition ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Enteral Nutrition and Parenteral Nutrition Growth Accelerators and Market Barriers
Table 37. North America Enteral Nutrition and Parenteral Nutrition Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Enteral Nutrition and Parenteral Nutrition Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Enteral Nutrition and Parenteral Nutrition Growth Accelerators and Market Barriers
Table 40. Europe Enteral Nutrition and Parenteral Nutrition Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Enteral Nutrition and Parenteral Nutrition Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Enteral Nutrition and Parenteral Nutrition Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Enteral Nutrition and Parenteral Nutrition Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Enteral Nutrition and Parenteral Nutrition Growth Accelerators and Market Barriers
Table 45. Southeast Asia Enteral Nutrition and Parenteral Nutrition Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Enteral Nutrition and Parenteral Nutrition Investment Opportunities and Key Challenges
Table 47. Central and South America Enteral Nutrition and Parenteral Nutrition Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Enteral Nutrition and Parenteral Nutrition Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Enteral Nutrition and Parenteral Nutrition Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Abbott Corporation Information
Table 51. Abbott Description and Major Businesses
Table 52. Abbott Product Models, Descriptions and Specifications
Table 53. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Abbott Sales Value Proportion by Product in 2024
Table 55. Abbott Sales Value Proportion by Application in 2024
Table 56. Abbott Sales Value Proportion by Geographic Area in 2024
Table 57. Abbott Enteral Nutrition and Parenteral Nutrition SWOT Analysis
Table 58. Abbott Recent Developments
Table 59. B. Braun Corporation Information
Table 60. B. Braun Description and Major Businesses
Table 61. B. Braun Product Models, Descriptions and Specifications
Table 62. B. Braun Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. B. Braun Sales Value Proportion by Product in 2024
Table 64. B. Braun Sales Value Proportion by Application in 2024
Table 65. B. Braun Sales Value Proportion by Geographic Area in 2024
Table 66. B. Braun Enteral Nutrition and Parenteral Nutrition SWOT Analysis
Table 67. B. Braun Recent Developments
Table 68. Baxter Corporation Information
Table 69. Baxter Description and Major Businesses
Table 70. Baxter Product Models, Descriptions and Specifications
Table 71. Baxter Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Baxter Sales Value Proportion by Product in 2024
Table 73. Baxter Sales Value Proportion by Application in 2024
Table 74. Baxter Sales Value Proportion by Geographic Area in 2024
Table 75. Baxter Enteral Nutrition and Parenteral Nutrition SWOT Analysis
Table 76. Baxter Recent Developments
Table 77. BBCA Pharmaceutical Corporation Information
Table 78. BBCA Pharmaceutical Description and Major Businesses
Table 79. BBCA Pharmaceutical Product Models, Descriptions and Specifications
Table 80. BBCA Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. BBCA Pharmaceutical Sales Value Proportion by Product in 2024
Table 82. BBCA Pharmaceutical Sales Value Proportion by Application in 2024
Table 83. BBCA Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 84. BBCA Pharmaceutical Enteral Nutrition and Parenteral Nutrition SWOT Analysis
Table 85. BBCA Pharmaceutical Recent Developments
Table 86. Biokin Pharmaceutical Corporation Information
Table 87. Biokin Pharmaceutical Description and Major Businesses
Table 88. Biokin Pharmaceutical Product Models, Descriptions and Specifications
Table 89. Biokin Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Biokin Pharmaceutical Sales Value Proportion by Product in 2024
Table 91. Biokin Pharmaceutical Sales Value Proportion by Application in 2024
Table 92. Biokin Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 93. Biokin Pharmaceutical Enteral Nutrition and Parenteral Nutrition SWOT Analysis
Table 94. Biokin Pharmaceutical Recent Developments
Table 95. China Meheco Kangli Corporation Information
Table 96. China Meheco Kangli Description and Major Businesses
Table 97. China Meheco Kangli Product Models, Descriptions and Specifications
Table 98. China Meheco Kangli Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. China Meheco Kangli Recent Developments
Table 100. Cisen Corporation Information
Table 101. Cisen Description and Major Businesses
Table 102. Cisen Product Models, Descriptions and Specifications
Table 103. Cisen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Cisen Recent Developments
Table 105. Danone Corporation Information
Table 106. Danone Description and Major Businesses
Table 107. Danone Product Models, Descriptions and Specifications
Table 108. Danone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Danone Recent Developments
Table 110. Fresenius Kabi Corporation Information
Table 111. Fresenius Kabi Description and Major Businesses
Table 112. Fresenius Kabi Product Models, Descriptions and Specifications
Table 113. Fresenius Kabi Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Fresenius Kabi Recent Developments
Table 115. Grand Life Sciences Corporation Information
Table 116. Grand Life Sciences Description and Major Businesses
Table 117. Grand Life Sciences Product Models, Descriptions and Specifications
Table 118. Grand Life Sciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Grand Life Sciences Recent Developments
Table 120. Haisco Pharmaceutical Group Corporation Information
Table 121. Haisco Pharmaceutical Group Description and Major Businesses
Table 122. Haisco Pharmaceutical Group Product Models, Descriptions and Specifications
Table 123. Haisco Pharmaceutical Group Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Haisco Pharmaceutical Group Recent Developments
Table 125. JW Pharmaceutical Corporation Information
Table 126. JW Pharmaceutical Description and Major Businesses
Table 127. JW Pharmaceutical Product Models, Descriptions and Specifications
Table 128. JW Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. JW Pharmaceutical Recent Developments
Table 130. Kelun Pharma Corporation Information
Table 131. Kelun Pharma Description and Major Businesses
Table 132. Kelun Pharma Product Models, Descriptions and Specifications
Table 133. Kelun Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Kelun Pharma Recent Developments
Table 135. King York Corporation Information
Table 136. King York Description and Major Businesses
Table 137. King York Product Models, Descriptions and Specifications
Table 138. King York Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. King York Recent Developments
Table 140. Lionco Pharmaceutical Corporation Information
Table 141. Lionco Pharmaceutical Description and Major Businesses
Table 142. Lionco Pharmaceutical Product Models, Descriptions and Specifications
Table 143. Lionco Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Lionco Pharmaceutical Recent Developments
Table 145. Lummy Corporation Information
Table 146. Lummy Description and Major Businesses
Table 147. Lummy Product Models, Descriptions and Specifications
Table 148. Lummy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Lummy Recent Developments
Table 150. Medisan Corporation Information
Table 151. Medisan Description and Major Businesses
Table 152. Medisan Product Models, Descriptions and Specifications
Table 153. Medisan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Medisan Recent Developments
Table 155. Medtrition Corporation Information
Table 156. Medtrition Description and Major Businesses
Table 157. Medtrition Product Models, Descriptions and Specifications
Table 158. Medtrition Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 159. Medtrition Recent Developments
Table 160. Nestlé S.A. Corporation Information
Table 161. Nestlé S.A. Description and Major Businesses
Table 162. Nestlé S.A. Product Models, Descriptions and Specifications
Table 163. Nestlé S.A. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 164. Nestlé S.A. Recent Developments
Table 165. Otsuka Pharmaceutical Corporation Information
Table 166. Otsuka Pharmaceutical Description and Major Businesses
Table 167. Otsuka Pharmaceutical Product Models, Descriptions and Specifications
Table 168. Otsuka Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 169. Otsuka Pharmaceutical Recent Developments
Table 170. Pfizer Corporation Information
Table 171. Pfizer Description and Major Businesses
Table 172. Pfizer Product Models, Descriptions and Specifications
Table 173. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 174. Pfizer Recent Developments
Table 175. Teva Pharmaceutical Corporation Information
Table 176. Teva Pharmaceutical Description and Major Businesses
Table 177. Teva Pharmaceutical Product Models, Descriptions and Specifications
Table 178. Teva Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 179. Teva Pharmaceutical Recent Developments
Table 180. Xi'an Libang Pharmaceutical Corporation Information
Table 181. Xi'an Libang Pharmaceutical Description and Major Businesses
Table 182. Xi'an Libang Pharmaceutical Product Models, Descriptions and Specifications
Table 183. Xi'an Libang Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 184. Xi'an Libang Pharmaceutical Recent Developments
Table 185. Key Raw Materials Distribution
Table 186. Raw Materials Key Suppliers
Table 187. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 188. Milestones in Production Technology Evolution
Table 189. Distributors List
Table 190. Market Trends and Market Evolution
Table 191. Market Drivers and Opportunities
Table 192. Market Challenges, Risks, and Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources


List of Figures
Figure 1. Enteral Nutrition and Parenteral Nutrition Product Picture
Figure 2. Global Enteral Nutrition and Parenteral Nutrition Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Oral/Tube Feeding Product Picture
Figure 4. Intravenous Injection Product Picture
Figure 5. Global Enteral Nutrition and Parenteral Nutrition Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Hospital Clinic
Figure 7. Pharmacy
Figure 8. Others
Figure 9. Enteral Nutrition and Parenteral Nutrition Report Years Considered
Figure 10. Global Enteral Nutrition and Parenteral Nutrition Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Enteral Nutrition and Parenteral Nutrition Revenue (2020-2031) & (US$ Million)
Figure 12. Global Enteral Nutrition and Parenteral Nutrition Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Enteral Nutrition and Parenteral Nutrition Revenue Market Share by Region (2020-2031)
Figure 14. Global Enteral Nutrition and Parenteral Nutrition Sales (2020-2031) & (K Units)
Figure 15. Global Enteral Nutrition and Parenteral Nutrition Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global Enteral Nutrition and Parenteral Nutrition Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers Enteral Nutrition and Parenteral Nutrition Sales Volume Market Share in 2024
Figure 18. Global Enteral Nutrition and Parenteral Nutrition Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Oral/Tube Feeding Revenue Market Share by Manufacturer in 2024
Figure 21. Intravenous Injection Revenue Market Share by Manufacturer in 2024
Figure 22. Global Enteral Nutrition and Parenteral Nutrition Sales Market Share by Type (2020-2031)
Figure 23. Global Enteral Nutrition and Parenteral Nutrition Revenue Market Share by Type (2020-2031)
Figure 24. Global Enteral Nutrition and Parenteral Nutrition Sales Market Share by Application (2020-2031)
Figure 25. Global Enteral Nutrition and Parenteral Nutrition Revenue Market Share by Application (2020-2031)
Figure 26. North America Enteral Nutrition and Parenteral Nutrition Sales YoY (2020-2031) & (K Units)
Figure 27. North America Enteral Nutrition and Parenteral Nutrition Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers Enteral Nutrition and Parenteral Nutrition Sales Revenue (US$ Million) in 2024
Figure 29. North America Enteral Nutrition and Parenteral Nutrition Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America Enteral Nutrition and Parenteral Nutrition Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America Enteral Nutrition and Parenteral Nutrition Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America Enteral Nutrition and Parenteral Nutrition Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US Enteral Nutrition and Parenteral Nutrition Revenue (2020-2031) & (US$ Million)
Figure 34. Canada Enteral Nutrition and Parenteral Nutrition Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico Enteral Nutrition and Parenteral Nutrition Revenue (2020-2031) & (US$ Million)
Figure 36. Europe Enteral Nutrition and Parenteral Nutrition Sales YoY (2020-2031) & (K Units)
Figure 37. Europe Enteral Nutrition and Parenteral Nutrition Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers Enteral Nutrition and Parenteral Nutrition Sales Revenue (US$ Million) in 2024
Figure 39. Europe Enteral Nutrition and Parenteral Nutrition Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe Enteral Nutrition and Parenteral Nutrition Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe Enteral Nutrition and Parenteral Nutrition Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe Enteral Nutrition and Parenteral Nutrition Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany Enteral Nutrition and Parenteral Nutrition Revenue (2020-2031) & (US$ Million)
Figure 44. France Enteral Nutrition and Parenteral Nutrition Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. Enteral Nutrition and Parenteral Nutrition Revenue (2020-2031) & (US$ Million)
Figure 46. Italy Enteral Nutrition and Parenteral Nutrition Revenue (2020-2031) & (US$ Million)
Figure 47. Russia Enteral Nutrition and Parenteral Nutrition Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific Enteral Nutrition and Parenteral Nutrition Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific Enteral Nutrition and Parenteral Nutrition Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers Enteral Nutrition and Parenteral Nutrition Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific Enteral Nutrition and Parenteral Nutrition Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific Enteral Nutrition and Parenteral Nutrition Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific Enteral Nutrition and Parenteral Nutrition Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific Enteral Nutrition and Parenteral Nutrition Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia Enteral Nutrition and Parenteral Nutrition Revenue (2020-2031) & (US$ Million)
Figure 56. Japan Enteral Nutrition and Parenteral Nutrition Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea Enteral Nutrition and Parenteral Nutrition Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan Enteral Nutrition and Parenteral Nutrition Revenue (2020-2031) & (US$ Million)
Figure 59. India Enteral Nutrition and Parenteral Nutrition Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America Enteral Nutrition and Parenteral Nutrition Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America Enteral Nutrition and Parenteral Nutrition Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers Enteral Nutrition and Parenteral Nutrition Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America Enteral Nutrition and Parenteral Nutrition Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America Enteral Nutrition and Parenteral Nutrition Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America Enteral Nutrition and Parenteral Nutrition Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America Enteral Nutrition and Parenteral Nutrition Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil Enteral Nutrition and Parenteral Nutrition Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina Enteral Nutrition and Parenteral Nutrition Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa Enteral Nutrition and Parenteral Nutrition Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa Enteral Nutrition and Parenteral Nutrition Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers Enteral Nutrition and Parenteral Nutrition Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa Enteral Nutrition and Parenteral Nutrition Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America Enteral Nutrition and Parenteral Nutrition Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa Enteral Nutrition and Parenteral Nutrition Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa Enteral Nutrition and Parenteral Nutrition Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries Enteral Nutrition and Parenteral Nutrition Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey Enteral Nutrition and Parenteral Nutrition Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt Enteral Nutrition and Parenteral Nutrition Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa Enteral Nutrition and Parenteral Nutrition Revenue (2020-2025) & (US$ Million)
Figure 80. Enteral Nutrition and Parenteral Nutrition Industry Chain Mapping
Figure 81. Regional Enteral Nutrition and Parenteral Nutrition Manufacturing Base Distribution (%)
Figure 82. Global Enteral Nutrition and Parenteral Nutrition Production Market Share by Region (2020-2031)
Figure 83. Enteral Nutrition and Parenteral Nutrition Production Process
Figure 84. Regional Enteral Nutrition and Parenteral Nutrition Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit